Overview
Francesca Crupi practices in Florence, Italy. Ms. Crupi is rated as an Advanced expert by MediFind in the treatment of Hereditary Alpha-Tryptasemia. Her top areas of expertise are Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Hereditary Alpha-Tryptasemia, and Acute Myeloid Leukemia (AML).
Her clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Hereditary Alpha-Tryptasemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hereditary Alpha-TryptasemiaMs. Crupi isAdvanced. Learn about Hereditary Alpha-Tryptasemia.
- Mast Cell Activation Syndrome (MCAS)
- Systemic MastocytosisMs. Crupi isAdvanced. Learn about Systemic Mastocytosis.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Crupi isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Familial HypertriglyceridemiaMs. Crupi isExperienced. Learn about Familial Hypertriglyceridemia.
- LeukemiaMs. Crupi isExperienced. Learn about Leukemia.